中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Progress in folate receptor-mediated anticancer agent delivery

文献类型:期刊论文

作者Fu Liqiang; Ding Shi; Yang Yushe
刊名Chinese Journal of Medicinal Chemistry
出版日期2013
卷号23期号:3页码:226-234
关键词folate receptor endocytosis folate conjugate anticancer drug
ISSN号1005-0108
其他题名叶酸受体介导的小分子抗肿瘤药物研究进展
文献子类Review
英文摘要Cancer therapies that exploit targeting ligands to deliver attached cytotoxic drugs selectively to malignant cells are currently receiving significant attention.The folate receptor(FR) is a confirmed tumor-associated antigen that binds folate and folate-drug conjugates with very high affinity and shuttles these bound molecules inside cells via an endocytic mechanism.With the use of proper linkers and cleavable bond,small molecular weight,highly potent anticancer drugs can be released inside the cancer cells where they can perform their desired cytotoxic functions.This review summarizes published activity data of various conjugates and highlights some newly emerging data from novel compounds which are currently under clinical investigation.
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:4852862
源URL[http://119.78.100.183/handle/2S10ELR8/267777]  
专题药物化学研究室
通讯作者Yang Yushe
作者单位State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Fu Liqiang,Ding Shi,Yang Yushe. Progress in folate receptor-mediated anticancer agent delivery[J]. Chinese Journal of Medicinal Chemistry,2013,23(3):226-234.
APA Fu Liqiang,Ding Shi,&Yang Yushe.(2013).Progress in folate receptor-mediated anticancer agent delivery.Chinese Journal of Medicinal Chemistry,23(3),226-234.
MLA Fu Liqiang,et al."Progress in folate receptor-mediated anticancer agent delivery".Chinese Journal of Medicinal Chemistry 23.3(2013):226-234.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。